AstraZeneca PLC
1462,00
22-ноября-24 11:29:38
15 мин. задержка
Акции
+48,50
+3,43%
Сегодняшний диапазон
1419,00 - 1471,50
ISIN
N/A
Источник
NASD.OMX SE
- Котировки
- Графики
Новости
- Статистика
-
AstraZeneca Paying Up To $2 Billion For Experimental Obesity Pill—As Weight Loss Drug Market Grows
09 ноя 2023 09:57:51 Источник Forbes - World
-
09 ноя 2023 06:19:20 Источник MarketWatch
-
09 ноя 2023 05:10:57 Источник MarketWatch
-
AstraZeneca Reaches Obesity Drug Deal; Imfinzi Combination Meets Main Goal In Liver Cancer Trial
09 ноя 2023 03:55:26 Источник NASDAQ US Markets
-
AstraZeneca Q3 Pre-tax Profit Climbs; Lifts FY Outlook
09 ноя 2023 03:28:56 Источник NASDAQ US Markets
-
US FTC disputes listing for more than 100 patents in FDA Orange Book
07 ноя 2023 13:01:35 Источник NASDAQ US Markets
-
AstraZeneca (AZN) to Report Q3 Earnings: What's in the Cards?
06 ноя 2023 14:44:08 Источник NASDAQ Stocks
-
AstraZeneca : Canada Approves Ultomiris For Adults With Neuromyelitis Optica Spectrum Disorder
01 ноя 2023 07:46:39 Источник NASDAQ US Markets
-
Cellectis Announces Collaboration Agreement With AstraZeneca; To Receive Up To $245 Mln
01 ноя 2023 05:05:04 Источник NASDAQ US Markets
-
Here’s Why You Could Be Giving Yourself—Or Someone Else—A Flu Shot Next Year
24 окт 2023 08:18:46 Источник Forbes - World
-
AstraZeneca : FDA Accepts For Review SBLA For Self-administration Of Flumist Quadrivalent
24 окт 2023 07:49:37 Источник NASDAQ US Markets
-
AstraZeneca : Enhertu Approved In EU For Advanced Non-small Cell Lung Cancer Treatment
23 окт 2023 03:05:09 Источник NASDAQ US Markets
-
AZN : Imfinzi Combination Reduces Risk Of Disease Progression Or Death By 45% In Endometrial Cancer
21 окт 2023 11:33:24 Источник NASDAQ US Markets
-
AstraZeneca: 59% Of Patients Treated With Tagrisso + Chemotherapy Had Complete Brain Tumor Responses
21 окт 2023 11:33:23 Источник NASDAQ US Markets
-
AstraZeneca: TAGRISSO Plus Chemotherapy Granted Priority Review By FDA
16 окт 2023 07:36:08 Источник NASDAQ US Markets
-
Ascentage, AstraZeneca Collaborate On Phase III Study Of Lisaftoclax Combination In CLL/SLL
15 окт 2023 23:53:04 Источник NASDAQ US Markets
-
AstraZeneca Settles Lawsuits Alleging Heartburn Drugs Caused Kidney Disease For $425 Million
03 окт 2023 09:12:46 Источник Forbes - World
-
AstraZeneca Settles Nexium, Prilosec Product Liability Litigations; To Pay $425 Mln
03 окт 2023 03:04:52 Источник NASDAQ US Markets
-
29 сен 2023 10:53:27 Источник MarketWatch
-
AstraZeneca PLC (AZN) Is a Trending Stock: Facts to Know Before Betting on It
26 сен 2023 10:10:15 Источник NASDAQ Stocks